Best in Biotech 20 Oct 2025 Five latest advancements in Tourette’s syndrome research Discover recent Tourette’s syndrome research, highlighting emerging therapies and biotech advances in this neurological disorder. October 20, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2025 AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome (CRPS). October 7, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2025 Targeting orexin: the future of narcolepsy treatments There are a few new narcolepsy treatments being tested in the clinic, and recently, some of them have made promising strides. But how far along are they? July 30, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2025 A new era in migraine treatment: Innovative drugs redefining the field Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better. June 13, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Mar 2025 How biotechs are using AI to rescue failed drugs Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs. March 17, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2025 Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree? This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues. February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Dec 2024 10 biotech companies to watch in 2025 As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025. December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2024 Charcot–Marie–Tooth disease: what’s going on in the clinical field? In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease. November 27, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Spatial Transcriptomics: A window into disease The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? October 30, 2024 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored by Angelini Pharma 15 Oct 2024 The future of epilepsy treatment: pioneering advances and patient-centric care Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated to be living with the disease. Whilst treatment options have come a long way over the last few decades, clinical practice still shows significant unmet […] October 15, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Reports 25 Sep 2024Current trends & innovations in 3D organoids Discover how 3D organoids are already shaping research & drug development today and explore their future potential. September 25, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 12 Sep 2024New treatments being developed for schizophrenia Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials. September 12, 2024 Share WhatsApp Twitter Linkedin Email